Skip to content

Clinical trials

Observational Leukemia, Myeloid, Acute trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Observational Country / region: China Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20121
20131
20142
20171
20183
20201
20212
20224
20235
20244
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13
Recruiting11
Completed8
Not yet recruiting3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University6
The First Affiliated Hospital of Soochow University5
Institute of Hematology & Blood Diseases Hospital, China4
Peking University People's Hospital3
Bristol-Myers Squibb2
Ruijin Hospital2
The Children's Hospital of Zhejiang University School of Medicine2
Astellas Pharma Singapore Pte. Ltd.1
First Affiliated Hospital of Jinan University1
Fujian Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute37
Leukemia6
Myelodysplastic Syndromes6
Lymphoma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Anemia, Aplastic3
Multiple Myeloma3
Hematologic Diseases2
Hemophilia A2
Hemostatic Disorders2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.